Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 9,221–9,240 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

Methyl-Cobalamin injectable, 2 mg/mL, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Enanthate/Cypionate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate/Enanthate injectable, 200/50 mg/mL, packaged in a) 5 mL and 8 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate/Enanthate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Dexpanthenol injectable, 250 mg/mL, 10 mL Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Recall initiated
August 21, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide in USA

View recall →

Drug Recall Terminated Historical recordClass II

Ipamorelin 9 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin 4000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin 2500 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin 20000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Human Chorionic Gonadotropin 11000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Recall initiated
August 2, 2018
Reported by FDA
September 5, 2018
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.